Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Device Capable of Reading Multiple Cardiac Vital Signs Offers Smarter Way to Monitor Critical Care Patients

By HospiMedica International staff writers
Posted on 27 Jun 2023

Patients undergoing surgery or intensive care face an increased risk of mortality and prolonged hospital stays due to their vulnerability to hypotension and hemodynamic instability, or irregular blood flow. Such potential complications necessitate continuous monitoring of several cardiac functions by healthcare professionals. However, there's currently no single, user-friendly device in the market capable of measuring the most critical aspects of a patient's cardiovascular health. Researchers are now in the process of developing a multifunctional device that can independently and reliably monitor blood pressure, cardiac output, and ventricular ejection fraction.

The “Smart Cuff” being developed by researchers at University of Pittsburgh (Pittsburgh, PA, USA) is a versatile device designed to monitor multiple cardiac vital signs. The process begins by placing a cuff around the patient's arm and inflating it to the point where blood flow through the brachial artery is halted. Gradual deflation of the cuff generates a waveform - a crucial component of the Smart Cuff. This waveform is used to compute blood pressure. The Smart Cuff, using machine learning inspired by physiology and innovative cuff inflation-deflation patterns, is capable of calculating cardiac output and other significant variables. These include pulse pressure variations and left ventricular ejection fraction, indicating the effectiveness of the heart in pumping oxygen-rich blood throughout the body.

“Several hemodynamic monitoring devices are currently available, but they are invasive, manual or nonstandard,” said Ramakrishna Mukkamala, professor of bioengineering at the University of Pittsburgh Swanson School of Engineering. “None have been widely adopted. Smart Cuff, which is worn on a patient’s arm just like a typical blood pressure cuff in critical care, can eliminate all these hurdles and allow for more efficient patient care.”

“Blood pressure is vital for monitoring hypotension and other potential risks to patients, but cardiac output and left ventricular ejection fraction are needed to determine treatment,” Mukkamala added. “Our goal here is to improve a patient’s cardiovascular outcomes and simplify evaluation tools for medical professionals.”

Related Links:
University of Pittsburgh 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Portable Ventilator
Oxivent Life
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.